搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
2 天
on MSN
Ewing’s Sarcoma: What you need to know about this rare peadiatric bone cancer
Ewing sarcoma is a rare type of cancer that primarily affects bones or soft tissues in children and young adults. Symptoms ...
3 天
New tumor models provide insights into deadly sarcomas
Sarcomas are highly metastatic soft tissue and bone cancers and are often difficult to treat. Scientists have had trouble ...
13 天
on MSN
Understanding sarcoma: A guide for parents and new advances in treatment
Sarcoma, a rare cancer in connective tissues, needs specialized treatment. Early detection via MRIs is vital. Modern ...
Cure Today
8 天
FDA Approves Subcutaneous Tecentriq Formulation
Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin ...
Monthly Prescribing Reference
7 天
FDA Approves Tecentriq Hybreza, a Subcutaneously Administered PD-L1 Inhibitor
and alveolar soft part sarcoma. Tecentriq Hybreza is a combination of atezolizumab, a programmed death-ligand 1 (PD-L1) blocking antibody, and hyaluronidase, an endoglycosidase that increases the ...
Business Wire
8 天
FDA Approves Genentech’s Tecentriq Hybreza, the First and Only Subcutaneous Anti-PD-(L)1 ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...
GMA News Online on MSN
7 天
Doc Willie Ong announces cancer diagnosis
Cardiologist Willie Ong, a health advocate who ran for vice president in Eleksyon 2022, is fighting the battle for his life ...
Philippine News
4 天
Doc Willie Ong – About Sarcoma Cancer
DOC WILLIE ONG - Here are some things to know about sarcoma cancer, the disease the health advocate is currently suffering ...
Targeted Oncology
8 天
FDA Grants Elraglusib Orphan Drug Designation in Soft Tissue Sarcoma
The FDA granted orphan drug designation for elraglusib, a novel drug for treating advanced soft tissue sarcoma.
9 天
Adaptimmune's T-Cell Therapy Journey: A Small Market, Big Ambitions
Adaptimmune received FDA approval for Tecelra, with a 39% response rate in synovial sarcoma. See why I rate ADAP stock as a ...
holsworthy-today
2 天
Selfless local helps raise thousands for charity with funky music event
A SELFLESS Launceston resident has helped raise thousands for a vital cancer charity, all while busting some moves.
The American Journal of Managed Care
8 天
Elraglusib Granted FDA Orphan Drug Status in Soft Tissue Sarcoma
The FDA granted orphan drug designation for elraglusib, a novel drug for treating advanced soft tissue sarcoma.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈